Artificial biocornea material is derived from fishscale

Article

Scientists in The Netherlands have received an innovation grant to finalise the specification of a collagen, derived from fishscale, which will act as an alternative material for cornea regeneration.

Scientists in The Netherlands have received an innovation grant to finalise the specification of a collagen, derived from fishscale, which will act as an alternative material for cornea regeneration.

The Department of Ophthalmology of the Leids Universitair Medisch Centrum (LUMC) and Aeon Astron Europe BV (AAE) have officially joined forces to develop the artificial biocornea.

Julio Lin and his team in Taiwan, developed a fishscale-derived collagen scaffold as an alternative material for corneal regeneration. AAE will conduct further research to finalize the specification of the artificial biocornea under supervision of Dr J. Martine Jager, M.D., PhD., former ARVO President, and Prof Dr. G.P.M. Luyten, Head of the Ophthalmology Department of the LUMC.

AAE will transfer the technology and knowledge of the biodegradable biocornea to the LUMC. Michael Lai, CEO, says that AAE has experience in coordinating with the ophthalmologist opinion leaders worldwide and this bio-artificial cornea is the second ophthalmic product AAE is working on.

The LUMC team will undertake the efficacy evaluation in animal models of corneal regeneration and will test the biocompatibility with living cornea cells. The final specification of biocornea will be done through further in vitro and in vivo studies. On completion of the proect it is anticiapted that a human pilot study will get underway. This is a two-year project with a total budget of 1.5 million Euros.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.